BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20627789)

  • 1. Treatment of inflammatory muscle disease in adults.
    Tournadre A; Dubost JJ; Soubrier M
    Joint Bone Spine; 2010 Oct; 77(5):390-4. PubMed ID: 20627789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of polymyositis and dermatomyositis.
    Marie I; Mouthon L
    Autoimmun Rev; 2011 Nov; 11(1):6-13. PubMed ID: 21740984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of steroid-resistant polymyositis and dermatomyositis].
    Mimura T; Kanda H; Kubo K
    Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.
    Moghadam-Kia S; Aggarwal R; Oddis CV
    Expert Rev Clin Immunol; 2015; 11(11):1265-75. PubMed ID: 26313852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the pharmacological treatment of adult myositis.
    Oddis CV
    J Intern Med; 2016 Jul; 280(1):63-74. PubMed ID: 27098592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of polymyositis and dermatomyositis.
    Marie I
    Presse Med; 2011 Apr; 40(4 Pt 2):e257-70. PubMed ID: 21334847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab and mycophenolate combination therapy in refractory dermatomyositis with multiple autoimmune disorders.
    Parziale N; Kovacs SC; Thomas CB; Srinivasan J
    J Clin Neuromuscul Dis; 2011 Dec; 13(2):63-7. PubMed ID: 22361690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the inflammatory myopathies: update and practical recommendations.
    Hengstman GJ; van den Hoogen FH; van Engelen BG
    Expert Opin Pharmacother; 2009 May; 10(7):1183-90. PubMed ID: 19405792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of myositis].
    Keck AD; Walker UA
    Z Rheumatol; 2013 Apr; 72(3):227-35. PubMed ID: 23456367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab.
    Sharma AP; Filler G
    Pediatr Nephrol; 2009 Feb; 24(2):423-4. PubMed ID: 18853197
    [No Abstract]   [Full Text] [Related]  

  • 17. Current diagnosis and treatment of polymyositis and dermatomyositis.
    Sasaki H; Kohsaka H
    Mod Rheumatol; 2018 Nov; 28(6):913-921. PubMed ID: 29669460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation.
    O'Connell N; Goodyer M; Gleeson M; Storey L; Williams M; Cotter M; O'Marcaigh A; Smith O
    Pediatr Transplant; 2014 Feb; 18(1):E22-4. PubMed ID: 24168326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials roundup in idiopathic inflammatory myopathies.
    Mann HF; Vencovský J
    Curr Opin Rheumatol; 2011 Nov; 23(6):605-11. PubMed ID: 21926626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approaches in myositis.
    Aggarwal R; Oddis CV
    Curr Rheumatol Rep; 2011 Jun; 13(3):182-91. PubMed ID: 21365210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.